HomeMDG1 • FRA
add
MediGene AG
Previous close
€0.060
Day range
€0.059 - €0.069
Year range
€0.059 - €2.34
Market cap
1.03M EUR
Avg Volume
8.45K
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.46M | -6.00% |
Operating expense | 5.22M | — |
Net income | -4.08M | — |
Net profit margin | -280.10 | — |
Earnings per share | — | — |
EBITDA | -3.75M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.02M | — |
Total assets | 28.81M | — |
Total liabilities | 9.15M | — |
Total equity | 19.66M | — |
Shares outstanding | 14.74M | — |
Price to book | 0.05 | — |
Return on assets | — | — |
Return on capital | -44.32% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -4.08M | — |
Cash from operations | -3.54M | — |
Cash from investing | 3.85M | — |
Cash from financing | 2.36M | — |
Net change in cash | 2.68M | — |
Free cash flow | — | — |
About
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
Founded
1994
Headquarters
Website
Employees
87
